Flower City Capital Kura Oncology, Inc. Put Options Transaction History
Flower City Capital
- $169 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KURA
# of Institutions
191Shares Held
79.4MCall Options Held
76KPut Options Held
85.8K-
Suvretta Capital Management, LLC New York, NY8.12MShares$50.3 Million1.61% of portfolio
-
Bvf Inc San Francisco, CA7.75MShares$48.1 Million2.25% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$43.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$40.7 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$33.2 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $415M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...